Vivos Therapeutics Dirección
Dirección controles de criterios 4/4
El CEO de Vivos Therapeutics es R. Huntsman , nombrado en Sep 2016, tiene una permanencia de 8.17 años. compensación anual total es $657.70K, compuesta por 70.5% salario y 29.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.53% de las acciones de la empresa, por valor de $215.53K. La antigüedad media del equipo directivo y de la junta directiva es de 2.8 años y 4.4 años, respectivamente.
Información clave
R. Huntsman
Chief Executive Officer (CEO)
US$657.7k
Compensación total
| Porcentaje del salario del CEO | 70.5% |
| Permanencia del CEO | 8.2yrs |
| Participación del CEO | 1.5% |
| Permanencia media de la dirección | 2.8yrs |
| Promedio de permanencia en la Junta Directiva | 4.4yrs |
Actualizaciones recientes de la dirección
Recent updates
Even With A 27% Surge, Cautious Investors Are Not Rewarding Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Performance Completely
Nov 12
Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Shares Leap 41% Yet They're Still Not Telling The Full Story
Sep 10It's Down 44% But Vivos Therapeutics, Inc. (NASDAQ:VVOS) Could Be Riskier Than It Looks
Apr 25It's Down 48% But Vivos Therapeutics, Inc. (NASDAQ:VVOS) Could Be Riskier Than It Looks
Feb 02Fewer Investors Than Expected Jumping On Vivos Therapeutics, Inc. (NASDAQ:VVOS)
Apr 18Vivos Therapeutics again delays Q2 2022 results
Aug 23Vivos Therapeutics signs exclusive distribution agreement with GM Instruments for US and Canada
Jun 29Vivos Therapeutics, Inc. (NASDAQ:VVOS) Analysts Are More Bearish Than They Used To Be
May 21Vivos Therapeutics: First Take After The Broad Market Sell-Off
Mar 06Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$13m |
| Jun 30 2024 | n/a | n/a | -US$12m |
| Mar 31 2024 | n/a | n/a | -US$16m |
| Dec 31 2023 | US$658k | US$463k | -US$14m |
| Sep 30 2023 | n/a | n/a | -US$15m |
| Jun 30 2023 | n/a | n/a | -US$19m |
| Mar 31 2023 | n/a | n/a | -US$20m |
| Dec 31 2022 | US$938k | US$385k | -US$24m |
| Sep 30 2022 | n/a | n/a | -US$25m |
| Jun 30 2022 | n/a | n/a | -US$25m |
| Mar 31 2022 | n/a | n/a | -US$22m |
| Dec 31 2021 | US$1m | US$344k | -US$20m |
| Sep 30 2021 | n/a | n/a | -US$24m |
| Jun 30 2021 | n/a | n/a | -US$21m |
| Mar 31 2021 | n/a | n/a | -US$19m |
| Dec 31 2020 | US$455k | US$252k | -US$18m |
| Sep 30 2020 | n/a | n/a | -US$9m |
| Jun 30 2020 | n/a | n/a | -US$11m |
| Mar 31 2020 | n/a | n/a | -US$12m |
| Dec 31 2019 | US$328k | US$249k | -US$12m |
| Dec 31 2018 | US$284k | US$249k | -US$9m |
Compensación vs. Mercado: La compensación total ($USD657.70K) de R. está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD650.80K).
Compensación vs. Ingresos: La compensación de R. ha sido consistente con los resultados de la empresa en el último año.
CEO
R. Huntsman (66 yo)
8.2yrs
Permanencia
US$657,701
Compensación
Mr. R. Kirk Hunstman is the Co-Founder of Vivos Therapeutics, Inc. since September 2016 and has been its Chief Executive Officer and Director since September 2016 and has been its Chairman of the Board sin...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 8.2yrs | US$657.70k | 1.53% $ 215.5k | |
| CFO, Treasurer & Secretary | 6.1yrs | US$400.04k | 0.0017% $ 236.2 | |
| Co-Founder & Senior VP of Product and Technology | less than a year | sin datos | sin datos | |
| Co-Founder and Senior VP of Events & Clinical Advisory Services | no data | sin datos | sin datos | |
| Co-Founder & Executive VP of Operations | less than a year | sin datos | sin datos | |
| Senior Vice President of Medical Integration Division | 5.1yrs | sin datos | sin datos | |
| Senior Vice President of Practice Services | no data | sin datos | sin datos | |
| Senior Vice President of Dental Service Integration | 2.8yrs | sin datos | sin datos | |
| Senior Vice President of Technology | less than a year | sin datos | sin datos |
2.8yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de VVOS se considera experimentado (2.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 8.2yrs | US$657.70k | 1.53% $ 215.5k | |
| Independent Director | 4.4yrs | US$63.00k | 0.0084% $ 1.2k | |
| Independent Director | 4.4yrs | US$58.00k | 0% $ 0 | |
| Independent Director | 4.4yrs | US$58.00k | 0% $ 0 | |
| Independent Director | 4.4yrs | US$63.00k | 0% $ 0 | |
| Member of Medical & Clinical Advisory Board | 3.8yrs | sin datos | sin datos | |
| Independent Director | 4.4yrs | US$58.00k | 0% $ 0 | |
| Member of Medical & Clinical Advisory Board | 3.8yrs | sin datos | sin datos | |
| Member of Medical & Clinical Advisory Board | 3.8yrs | sin datos | sin datos | |
| Member of Medical & Clinical Advisory Board | 3.8yrs | sin datos | sin datos | |
| Co-Chair of Medical & Clinical Advisory Board | 3.8yrs | sin datos | sin datos | |
| Co-Chair of Medical & Clinical Advisory Board | no data | sin datos | sin datos |
4.4yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de VVOS se considera experimentada (4.4 años de antigüedad promedio).